BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.

Mu J, Sun X, Zhao Z, Sun H, Sun P

DOI: 10.1038/s41419-021-04186-6
Published: 2021 Oct 19
Container: Cell death & disease
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41419-021-04186-6,
  title = {BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.},
  author = {Mu J and Sun X and Zhao Z and Sun H and Sun P},
  year = {2021},
  journal = {Cell death \& disease},
  doi = {10.1038/s41419-021-04186-6},
  url = {https://doi.org/10.1038/s41419-021-04186-6}
}

RIS

TY  - JOUR
TI  - BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.
AU  - Mu J
AU  - Sun X
AU  - Zhao Z
AU  - Sun H
AU  - Sun P
PY  - 2021
JO  - Cell death & disease
DO  - 10.1038/s41419-021-04186-6
UR  - https://doi.org/10.1038/s41419-021-04186-6
ER  -

APA

J, M., X, S., Z, Z., H, S., & P, S. (2021). BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.. Cell death & disease. https://doi.org/10.1038/s41419-021-04186-6

Source records

pubmed · retrieved 2026-09-25T20:51:13.174Z
europe-pmc · retrieved 2026-09-25T20:51:15.588Z
doaj · retrieved 2026-09-25T20:51:13.190Z